The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Natriuretic peptides: a new lipolytic pathway in human adipocytes
Abstract
Atrial natriuretic peptide (ANP) receptors have been described on rodent adipocytes and expression of their mRNA is found in human adipose tissue. However, no biological effects associated with the stimulation of these receptors have been reported in this tissue. A putative lipolytic effect of natriuretic peptides was investigated in human adipose tissue. On isolated fat cells, ANP and brain natriuretic peptide (BNP) stimulated lipolysis as much as isoproterenol, a nonselective β‐adrenergic receptor agonist, whereas C‐type natriuretic peptide (CNP) had the lowest lipolytic effect. In situ microdialysis experiments confirmed the potent lipolytic effect of ANP in abdominal s.c. adipose tissue of healthy subjects. A high level of ANP binding sites was identified in human adipocytes. The potency order defined in lipolysis (ANP > BNP > CNP) and the ANP‐induced cGMP production sustained the presence of type A natriuretic peptide receptor in human fat cells. Activation or inhibition of cGMP‐inhibited phosphodiesterase (PDE‐3B) (using insulin and OPC 3911, respectively) did not modify ANP‐induced lipolysis whereas the isoproterenol effect was decreased or increased. Moreover, inhibition of adenylyl cyclase activity (using a mixture of α 2 ‐adrenergic and adenosine A1 agonists receptors) did not change ANP‐ but suppressed isoproterenol‐induced lipolysis. The noninvolvement of the PDE‐3B was finally confirmed by measuring its activity under ANP stimulation. Thus, we demonstrate that natriuretic pep tides are a new pathway controlling human adipose tissue lipolysis operating via a cGMP‐dependent pathway that does not involve PDE‐3B inhibition and cAMP production.—Sengenès, C., Berlan, M., De Glisezinski, I., Lafontan, M., Galitzky, J. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J. 14, 1345–1351 (2000)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolism of Isolated Fat Cells
Rodbell, M. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51687-2 · Cited by 4,427
de Bold, A. J., Borenstein, H. B., Veress, A. T., & Sonnenberg, H. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90370-2 · Cited by 3,148
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
A new natriuretic peptide in porcine brain
Sudoh, T., Kangawa, K., Minamino, N., & Matsuo, H. (1988) · Nature · doi:10.1038/332078a0 · Cited by 1,816
METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS.
Rodbell, M. (1964) · PubMed · Cited by 1,387
Sudoh, T., Minamino, N., Kangawa, K., & Matsuo, H. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92401-k · Cited by 1,101
Subclasses of external adenosine receptors.
Londos, C., Cooper, D. M., & Wolff, J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2551 · Cited by 1,081
Fat cell adrenergic receptors and the control of white and brown fat cell function
Lafontan, M., & Berlan, M. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37695-1 · Cited by 641
Self-citationAdvances in second messenger and phosphoprotein research
(1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90270-s · Cited by 482
Anthonsen, M. W., Rönnstrand, L., Wernstedt, C., Degerman, E., & Holm, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.215 · Cited by 468
Structure, Localization, and Regulation of cGMP-inhibited Phosphodiesterase (PDE3)
Degerman, E., Belfrage, P., & Manganiello, V. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6823 · Cited by 428
Anand-Srivastava, M. B., Sairam, M. R., & Cantin, M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38925-2 · Cited by 282
Expression of natriuretic peptide receptors in human adipose and other tissues
Sarzani, P., Dessì-Fulgheri, P., Paci, V. M., Espinosa, E., & Rappelli, A. (1996) · Journal of Endocrinological Investigation · doi:10.1007/bf03349021 · Cited by 254
Fat Cell α2-Adrenoceptors: The Regulation of Fat CellFunction and Lipolysis*
LAFONTAN, M., & BERLAN, M. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-6-716 · Cited by 170
Self-citationRadiometric assays for glycerol, glucose, and glycogen
Bradley, D. C., & Kaslow, H. R. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90081-x · Cited by 117
Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue
Sarzani, R., Paci, V. M., Zingaretti, C. M., Pierleoni, C., Cinti, S., Cola, G., RAPPELLI, A., & Dess??-Fulgheri, P. (1995) · Journal of Hypertension · doi:10.1097/00004872-199511000-00004 · Cited by 104
Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue
Millet, L., Barbe, P., Lafontan, M., Berlan, M., & Galitzky, J. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.1.181 · Cited by 75 · cited 3×
“7 g/l) in order to estimate local SCAT blood flow changes (14).”
BackgroundMethodSelf-citationFat cell alpha 2-adrenoceptors: the regulation of fat cell function and lipolysis
Lafontan, M. (1995) · Endocrine Reviews · doi:10.1210/er.16.6.716 · Cited by 73
Self-citationIncrease in Circulating Insulin Induced by Atrial Natriuretic Peptide in Normal Humans
Uehlinger, D. E., Weidmann, P. U., Gnädinger, M. P., Hasler, L., Bachmann, C., Shaw, S., Hellmüller, B., & Lang, R. E. (1986) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198611000-00005 · Cited by 67
Scavone, C., Scanlon, C., McKee, M. L., & Nathanson, J. A. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24526-8 · Cited by 57
Jeandel, L., Okamura, H., Belles‐Isles, M., Chabot, J., Dihl, F., Morel, G., Kelly, P. A., & Heisler, S. (1989) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(89)90114-7 · Cited by 38
Localization of Atrial Natriuretic Factor Receptors in the Mesenteric Arterial Bed
León, H. D., Bonhomme, M.-C., Thibault, G., et al. (1995) · Circulation Research · doi:10.1161/01.res.77.1.64 · Cited by 31
Phosphorylation of hormone‐sensitive lipase by cyclic GMP‐dependent protein kinase
Strålfors, P., & Belfrage, P. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)81086-3 · Cited by 29
Manganiello, V. C., Degerman, E., Smith, C. J., Vasta, V., Tornqvist, H. E., & Belfrage, P. (1992) · PubMed · Cited by 26
Type III cyclic nucleotide phosphodiesterases and insulin action
Manganiello, V. C., Degerman, E., Taira, M., Kôno, T., & Belfrage, P. (1996) · Current topics in cellular regulation · doi:10.1016/s0070-2137(96)80003-3 · Cited by 25
Cited by
Brown and beige fat: Development, function and therapeutic potential
Harms, M., & Seale, P. (2013) · Nature Medicine · doi:10.1038/nm.3361 · Cited by 2,328
Impact of Obesity on Plasma Natriuretic Peptide Levels
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Wilson, P. W. F., & Vasan, R. S. (2004) · Circulation · doi:10.1161/01.cir.0000112582.16683.ea · Cited by 1,022
Potter, L. R., Abbey-Hosch, S., & Dickey, D. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0014 · Cited by 1,002
Neeland, I. J., Poirier, P., & Després, J.-P. (2018) · Circulation · doi:10.1161/circulationaha.117.029617 · Cited by 881
Bordicchia, M., Liu, D., Amri, E.-Z., Ailhaud, G., Dessì-Fulgheri, P., Zhang, C., Takahashi, N., Sarzani, R., & Collins, S. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59701 · Cited by 872
Metadata
- Authors
- Sengenès, C., Berlan, M., de Glisezinski, I., Lafontan, M., & Galitzky, J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2000-07
- Volume
- 14
- Issue
- 10
- Pages
- 1345-1351
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2046595938
- Cited by
- 532
- References
- 25
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.